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Introduction Miniaturization of instruments has changed the paradigms of percutaneous nephrolithotomy 
(PCNL). To date, however, few studies have analyzed the possible renal trauma generated by PCNL tract 
dilation. The purpose of this study is to evaluate and compare systematically the renal injury of all PNCL 
dilation techniques in pork kidneys (PK) and cadaveric kidney models (CK).
Material and methods Twelve dilation devices were tested (from 4.8 to 30 French (Fr)) including micro- 
and mini- PCNL kits, the Alken dilation set, 20 and 30 ATM balloons and the Amplatz set. Each device was 
tested six times in PK and CK. Morphologic analysis of tract defects of the different models and dilators 
were made measuring the longest axis and the area of renal parenchymal damage.
Results When comparing the PK and CK dilation tract areas to the device areas, major differences were 
seen with the 20 ATM 30 Fr balloon (p = 0.0001 and 0.008) respectively, the sequential Amplatz dilation  
to 30 Fr (p = 0.0005 and 0.0006) respectively, and the Alken 30 FR dilation (p = 0.012 and 0.02) respec-
tively. The 30 Fr dilations were 32.76 mm2 (mean) larger than the instruments themselves, while the ≤24 
Fr dilations were 11.6 mm2 (mean) larger than the instruments themselves.
Conclusions When comparing devices and tract areas, the dilation tract area exceeded device area  
by 11.6 mm2 at dilations up to 24 Fr vs. 32.76 mm2 with dilations of 30 Fr. Overall, PK had significantly  
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INTRODUCTION
Percutaneous nephrolithotomy (PCNL) is the cur-
rent standard of care for renal stones larger than 
2 cm [1]. Technological improvements have provided 
urologists with a wide armamentarium of dilation 
devices for kidney access, with sizes ranging from 
4.8 to 30 French (Fr) [2, 3, 4]. Miniaturization of 
instruments has impacted on indications, as small-
er tracts theoretically reduce complications such 
as blood loss [5, 6]. To date, however, few studies 
have analyzed the possible renal trauma generated 
by PCNL tract dilation [7, 8, 20]. These investiga-
tions have been done mainly in animal models to as-
sess the scar tissue after the procedure and the tract 
defect has rarely been described [9]. To our knowl-
edge, no studies have evaluated the renal damage 
in human cadaveric kidneys (CK) with the most re-
cent devices. 
The purpose of this study was to evaluate and com-
pare systematically the renal injury associated with 
all currently available PNCL dilation techniques 
in porcine kidney (PK) and CK models.
MATERIAL AND METHODS
Twelve dilation devices were tested: the 4.8 Fr Micro-
Perc® (Rocamed®); five dilators of the MIP: Minimally 
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Invasive PCNL™ kit (Karl Storz®): 8.5/9.5 Fr, 11/12 Fr, 
15/16 Fr, 16.5/17.5 and 21/22 Fr; two NephroMax™ 
(BostonScientific®) 20 ATM balloon dilators: 24 and 
30 Fr; two X-Force® (Bard®) 30 ATM balloon dila-
tors: 24 and 30 Fr; and the Alken (Karl Storz®) and 
Amplatz (Cook Medical®) sequential dilator sets. The 
dilations were performed in 11 PKs and in eight fresh 
human CKs in the upper, mid and lower poles, follow-
ing Brodel’s line and avoiding close dilations. The di-
lation sequence included a visually guided puncture 
with an 18-gauge Chiba needle into the collecting 
system through the renal papilla, with subsequent 
introduction of a PTFE-coated guidewire to guide 
the dilation device insertion. One-step dilations were 
performed with the MicroPerc®, the MIP™ kit, and 
the balloons. With the Amplatz kit over the PTFE 
catheter, sequential dilations to 24 Fr and 30 Fr were 
performed, as well as, two-step dilations using the 
16 and 30 Fr instruments. The Alken set dilation 
was tested with sequential dilations up to 24 and 
30 Fr. Each device was tested six times (three dilations 
in the PK and three in the CK). 
Sequential photographs were taken of each speci-
men. Measurements of the longest diameter and the 
superficial area of the capsule and renal parenchyma 
edges surrounding the tract were done with the his-
tologic analysis software Image J. Morphologic anal-
yses of tract defects and comparisons of the different 
models were performed. A two-way ANOVA test was 
used to compare results. A p value <0.05 was consid-
ered significant. 
Table 1. Mean dilation areas and mean dilation diameters for each device in pig and cadaver kidneys
RESULTS
Eleven PK bought at a local butchery and eight 
human CK from two females and two males with 
a mean age of 89 years (86–92 years) was used. 
Forty-five dilations were performed for both PK 
and CK. The area of the dilation devices was cal-
culated according to the manufacturer’s informa-
tion regarding the outer instrument diameter. All 
dilation devices had a circular shape and the areas 
ranged from 2.01 to 78.54 mm2 (Table 1). 
Morphologic evaluation
MicroPerc®: In both PK and CK, dilations were oval 
with clean edges and no parenchymal or capsule 
rupture.
MIP™: In PK, 8.5 to 16 Fr dilations resulted in an oc-
casional renal fissure of <1 mm. Using the 16.5/17.5 
Fr dilations, one 1.5-mm renal rupture appeared; this 
became more obvious with the 21/22 Fr instrument, 
and the oval shape was distorted into a V shape due 
to two or three renal fissures of 2–2.5 mm.
In CKs, dilations with the MIP™ had circular and 
oval shapes. The 8.5/9.5 to 16.5/17.5 Fr tracts 
showed 1-mm capsular retraction and fissures, while 
the 21/22 Fr tracts showed 1-mm renal rupture and 
capsular retraction.
Balloons: In PKs, dilations with the 24 and 30 Fr 20 
ATM balloons were oval and mostly displayed clean 














diameter Mean ±SD 
(mm)
MicroPerc (4.8) 1.6 2.01 0.52 ±0.16 1.05 ± 0.36 1.37 ±0.42 1.63 ±0.42
MiP-1 (8.5/9.5) 3.17 7.84 2.61 ±1.21 5.63 ± 0.93 2.71 ±0.89 3.18 ±0.73
MiP-2 (11/12) 4 12.57 7.05 ±1.06 5.61 ±0.46 4.60 ±0.19 3.24 ±0.26
MiP-3 (15/16) 5.3 22.06 11.52 ±3.73 8.90 ±3.43 6.28 ±1.29 4.44 ±0.64
MiP-4 (16.5/17.5) 5.8 26.42 12.97 ±3.26 13.20 ±2.03 6.05 ±1.07 5.51 ±0.94
MiP-5 (21/22) 7.3 42.2 27.89 ±24.97 23.98 ±6.26 10.58 ±1.14 8.54 ±1.28
Balloon 20 ATM-1 (24) 8 50.27 30.31 ±8.65 31.20 ±10.51 12.53 ±0.88 7.49 ±0.68
Balloon 20 ATM-2 (30) 10 78.54 34.23 ±13.81 47.60 ±1.54 14.58 ±0.65 10.80 ±1.03
Balloon 30 ATM-3 (24) 8 50.27 35.43 ±8.72 48.73 ±6.01 12.21 ±0.79 10.94 ±0.48
Balloon 30 ATM-4 (30) 10 78.54 80.97 ±16.82 57.13 ±12.80 16.31 ±1.05 12.82 ±0.94
Amplatz (sequential)-1 (24) 8 50.27 19.29 ±5.79 26.79 ±0.60 9.95 ±1.99 7.04 ±1.06
Amplatz (sequential)-2 (30) 10 78.54 38.71 ±11.02 38.83 ±6.98 13.66 ±2.39 11.45 ±1.51
Amplatz (two-step) (30) 10 78.54 62.08 ±7.17 49.99 ±11.48 15.80 ±3.56 11.62 ±3.58
ALKEN-1 (24) 8 50.27 32.73 ±11.63 30.18 ±2.78 10.17 ±1.13 9.17 ±1.36
ALKEN-2 (30) 10 78.54 48.81 ±7.54 50.78 ±4.35 11.70 ±1.83 10.54 ±0.80
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appeared. The 24 and 30 Fr 30 ATM balloons yielded 
consistent results, with large parenchymal disrup-
tions that became deep with the 30 Fr balloon. 
In the CK, the 24 and 30 Fr 20 ATM balloon dilations 
were oval and irregular, and the capsules had 1- to 
2.5-mm and 3- to 4-mm ruptures and retractions, re-
spectively. The 24 and 30 Fr 30 ATM balloons yielded 
similar results to the 20 ATM balloons, but the edges 
were even more irregular and tortuous.
Amplatz set: In the PK, the sequential dilation 
showed mainly distorted oval shapes, with one 
<2 mm renal fissure for the 24 Fr dilation and fis-
sures from 2 to 4 mm for the 30 Fr dilation. The 
two-step dilation produced deep renal ruptures 
of 2–4 mm in two specimens, while the third speci-
men had a V-shaped dilation due to two major deep 
fissures of 7 mm. In the CK, 24 and 30 Fr sequential 
dilations had clean edges. The 24 Fr dilation pro-
duced 1-mm ruptures and 2- to 3-mm capsule retrac-
tions, while the 30 Fr dilation resulted in a 4.4-mm 
capsule retraction and rupture. The two-step dila-
tion showed a 3- to 4-mm capsule retraction with 
rupture at both edges of the oval.
Alken set: In PK and CK, 24 Fr dilations showed un-
even edges and 1-mm fissures while 30 Fr tracts had 
oval shapes with 1- to 3-mm parenchymal fissures. 
Figure 1. Dilation morphology.
One PK specimen showed a major shape distortion 
due to a large 5-mm fissure. 
Examples of the dilations are shown in Figures 1 and 2. 
Dilation areas and diameters
Mean dilation areas ranged from 0.52 to 80.9 mm2 
in the PK and from 0.35 to 12.8 mm2 in the CK. The 
dilation diameters ranged from 1.37 to 16.31 mm in 
PK and 12.82 mm in CK (Table 1). 
Comparison of device area with the PK and CK dila-
tion tract areas (Figure 3) revealed major differences 
with the 20 ATM 30 Fr balloons (p = 0.0001 and 
0.008 respectively), the sequential Amplatz dilation 
to 30 Fr (p = 0.0005 and 0.0006 respectively), and 
the Alken 30 Fr dilation (p = 0.012 and 0.02 respec-
tively). The 30 Fr dilations were 32.76 mm2 (mean) 
larger than the instruments themselves, while the 
≤24 Fr dilations were 11.6 mm2 (mean) larger than 
the instruments themselves. The Amplatz two-step 
dilation was significantly larger only in the CK and 
the Alken 24 Fr dilation was significantly larger only 
in the PK (p = 0.0016 and 0.008 respectively). 
Upon comparison of the device diameters with the 
PK and CK dilation diameters (Figure 4), only the 
PK were found to have significantly larger injuries 
of renal hemorrhage ranging from 0.6% to 1.4% and 
that of transfusion from 11.2% to 17.5% [12, 13]. 
Tract dilation techniques have been studied as pos-
sible factors influencing bleeding and morbidity 
in PCNL. It has been suggested that use of balloons 
over Alken metal dilators reduces transfusion rates 
from 25% to 10% [14], although this claim is not con-
sistent with other literature [15]. The CROES study 
in a series of 5,537 patients found that balloon dila-
tion produces significantly more bleeding than tele-
scopic/serial dilation (9.4% vs. 6.7%, respectively; 
p <0.0001) and more transfusions (7.0% vs. 4.9%, 
respectively; p = 0.001) [16]. This can be explained 
by the increased laceration seen in this study, where 
balloon dilations produced increased blunt trauma, 
renal rupture, and tract irregularities than Alken 
and Amplatz dilators; this was especially evident 
with 30 Fr 30 ATM balloons. Similarly, an investi-
gation by Al-Kandari et al. [9] showed, in a eutha-
nized animal model, 25-mm V-shape fissured dilation 
tracts with 30 Fr balloons. 
Tract size also has an impact on postoperative 
morbidity, influencing both pain and hospital stay 
Central European Journal of Urology
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with the balloons (especially the 30 ATM 30 Fr, 
p = 0.0008) and Amplatz two-step dilation (p = 0.002).
When comparing the PK and CK tract diameters, 
significant differences were seen with the balloons 
(except in the 24 Fr 30 ATM device) and the Amplatz 
set when reaching 30 Fr with the two-step dilation 
and 24 Fr with the sequential dilation (p = 0.0017 
and 0.03 respectively). Comparison of PK and CK 
areas revealed significant differences only with the 
30 ATM 30 Fr balloon (p = 0.004). 
DISCUSSION
A variety of dilator sizes have been described for 
PCNL access, ranging from standard 30 Fr through 
‘mini’ dilators (13–24 Fr), more suitable for stones 
1.5–2 cm in size, to ‘ultramini’ dilators (11–13 Fr) 
and the MicroPerc® (4.8 Fr), preferred for stone sizes 
<1.5 cm [5, 10]. In the current study, we tested all 
the sizes and materials currently available. Success 
rates of PCNL exceed 90% [5, 19], and major compli-
cations were accordingly uncommon. Overall compli-
cation rates may reach 83% [11], with the incidence 
Figure 2. Dilation morphology.
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These clinical findings correlate with the morpho-
logical findings of this study. Overall, significant CK 
laceration and capsule rupture (2–7 mm) could be 
seen in dilations above 24 Fr, and Amplatz two-step 
dilations were associated with more evident cap-
sule fissures. One-step dilations below 22 Fr showed 
[6, 17]. Mishra et al. found a significantly reduced 
fall in hemoglobin with 15–20 Fr tracts compared 
with 24–30 Fr tracts: 0.8 ±0.9 g% vs. 1.3 ±0.4 g% 
(p = 0.01) [18]. The CROES study group also report-
ed 1.1% transfusion rates for 18 Fr Amplatz sheath 
sizes vs. 5.9% for sheath sizes from 27 to 30 Fr [16]. 
Figure 3. Device area vs. mean pig kidneys (PK) and cadaveric kidney models (CK) dilation areas (mm2).
Figure 4. Device diameter vs. mean pig kidneys (PK) and cadaveric kidney models (CK) diameters (mm).
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of renal damage between the semi-rigid 24 Fr and 
36 Fr balloon dilations at 6 weeks [7]. These findings 
are similar to those reported in other animal models 
by Traxer et al., who found no differences in terms 
of scarring of the tracts with 28 Fr balloons and 
11 Fr nephrostomy sheaths [20], and by Al-Kandari 
et al. after 30 Fr balloon and Amplatz sequential di-
lations [9]. Also, the volume used for <20 Fr PNCL 
is less than 1% of the renal volume [21] and medium- 
and long-term studies have shown no renal function 
damage [22, 23]. 
Based on the good outcomes of mini-PNCL [19], the 
trend toward fewer complications with smaller in-
struments [6, 17], and the results of this study, we 
consider that a reasonable recommendation would 
be to downsize standard PNCL dilations to tracts be-
tween 20 and 24 Fr. 
One potential limitation of this study is the stiffness 
of kidneys. Living pig kidneys can be more solid and 
tense, which, we believe, may produce different pa-
renchymal and capsule lesions than are found in ca-
daveric models. In addition, the use of living models 
permits evaluation of peri-renal bleeding. 
CONCLUSIONS
In this study both porcine and cadaveric model dila-
tion tracts up to 24 Fr had significantly smaller pa-
renchymal fissures and reduced capsule rupture than 
when compared with 30 Fr tracts. In this respect, 
it is to be noted that dilation tract area exceeded 
device area by 11.6 mm2 at dilations up to 24 Fr 
vs. 32.76 mm2 with dilations of 30 Fr. 
When comparing devices and tract areas, differences 
were significant at dilations above 24 Fr with all in-
struments, with one exception. Overall, morphologi-
cally PK had significantly larger injuries than the 
CK models. When comparing PK and CK tract di-
ameters, significant differences were seen with the 
balloons and Amplatz dilators.
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minimal (<2 mm) parenchymal lesions and capsule 
retractions. Major significant differences in both PK 
and CK dilation tract areas, compared with device 
area, were seen with 20 ATM 30 Fr balloons, sequen-
tial Amplatz dilation, and Alken 30 Fr dilation; with 
Amplatz two-step dilation a significant difference 
was observed only in the CK. 
Although reduced tract sizes have demonstrated 
good stone free rates of up to 86–96% for 13–18 Fr 
[17], longer operative times are seen [3, 18, 19]. 
To our knowledge, no previous studies have evalu-
ated PNCL tract dilations in cadaveric models. 
We found that dilations were morphologically differ-
ent in PK when compared with CK. Dilation diame-
ters were larger in PK, with the exception of the two 
smallest devices; nevertheless, there were almost 
no significant differences when comparing the dila-
tion areas. The reason for this result may be that 
human kidneys are stiffer and more rigid, so areas 
in PK collapsed more easily and fissures were larger. 
This could also explain why the PK started to show 
significant parenchymal fissures at dilations from 
22 Fr while CK started to show this feature only 
when reaching 30 Fr. Comparing PK with CK dila-
tion diameters, significant differences were seen with 
balloon dilators and Amplatz dilators when reaching 
30 Fr. Also, PK had significantly larger dilation ar-
eas compared with the instrument areas when using 
the balloons and Amplatz two-step dilations, while 
CK did not show any difference. With balloon dila-
tions, PK had larger renal fissures, but edges were 
cleaner than after CK tract expansion, which was as-
sociated with irregular edges; this was especially evi-
dent above 24 Fr. Dilation tracts with the Amplatz 
and Alken sets produced larger and more significant 
morphological damage in PK than in CK, particu-
larly at 30 Fr. All these differences cast into doubt 
whether PK can be truly reliable when studying 
PCNL, and further evaluations may better consider 
the use of CK. 
Nevertheless, no matter what the dilation size 
or the instrument used, studies have suggested that 
scarring is finally well achieved in all kidneys. Clay-
man et al. have shown in euthanized animal mod-
els that there is no significant difference in respect 
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